Utilization of a Novel Adaptive Dose Recalculation Tool in the Delivery of High-Dose Radiation for Intermediate- to High-Risk Prostate Cancer

被引:0
|
作者
Edwards-Bennett, S. M. [1 ]
Herbert, A. J. [1 ]
Key, S. M. [2 ]
Andrews, S. F. [1 ]
Francke, P. M. [1 ]
Barton, R. A. [1 ]
Swist, J. D. [1 ]
Hodges, C. B. [1 ]
Walls, R. L. [1 ]
Root, W. [1 ]
Mahan, S. L. [1 ]
Mantz, C. A. [3 ]
机构
[1] 21st Century Oncol, Myrtle Beach, SC USA
[2] 21st Century Oncol, Madison, WI USA
[3] 21st Century Oncol, Ft Myers, FL USA
关键词
D O I
10.1016/j.ijrobp.2014.05.2504
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3696
引用
收藏
页码:S877 / S878
页数:2
相关论文
共 50 条
  • [1] Outcomes of High-Dose Rate Brachytherapy for Intermediate- to High-Risk Prostate Cancer at One Institution
    Lin, E. Y.
    Lee, A.
    Demanes, J.
    Kamrava, M.
    Venkat, P. S.
    Hagio, M. A.
    Zaide, L. B.
    Park, S. J.
    Zarate, C.
    Chang, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E927 - E927
  • [2] Dose escalation with HDR brachytherapy for intermediate- and high-risk prostate cancer
    Chicas-Sett, R.
    Celada, F.
    Burgos, J.
    Farga, D.
    Perez-Calatayud, M.
    Roldan, S.
    Collado, E.
    Ibanez, B.
    Perez-Calatayud, J.
    Tormo, A.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S380 - S381
  • [3] High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features
    C Vargas
    A Martínez
    R Galalae
    J Demanes
    A Harsolia
    L Schour
    N Nuernberg
    J Gonzalez
    Prostate Cancer and Prostatic Diseases, 2006, 9 : 245 - 253
  • [4] High-dose radiation employing external beam radiotherapy and high-dose rate brachytherapy with and without neoadjuvant androgen deprivation for prostate cancer patients with intermediate- and high-risk features
    Vargas, C.
    Martinez, A.
    Galalae, R.
    Demanes, J.
    Harsolia, A.
    Schour, L.
    Nuernberg, N.
    Gonzalez, J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2006, 9 (03) : 245 - 253
  • [5] Comorbidity and androgen deprivation therapy use in men undergoing high-dose radiation for unfavorable intermediate- and high-risk prostate cancer.
    Dyer, Michael A.
    Chen, Ming-Hui
    Braccioforte, Michelle H.
    Moran, Brian Joseph
    D'Amico, Anthony V.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [6] Outcomes of High-Dose Rate (HDR) Brachytherapy in Intermediate- to High-Risk Prostate Cancer Patients with Prior Transurethral Resection of the Prostate (TURP)
    Lin, E. Y.
    Lee, A.
    Demanes, J.
    Kamrava, M.
    Venkat, P. S.
    Hagio, M. A.
    Zaide, L. B.
    Park, S. J.
    Zarate, C.
    Chang, A. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E888 - E888
  • [7] Significance of androgen-deprivation therapy for intermediate- and high-risk prostate cancer treated with high-dose radiotherapy: A literature review
    Aizawa, Rihito
    Ishikawa, Hitoshi
    Kato, Manabu
    Shimizu, Shosei
    Mizowaki, Takashi
    Kohjimoto, Yasuo
    Hinotsu, Shiro
    Hara, Isao
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1068 - 1079
  • [8] Randomized Phase 3 Trial of Adjuvant Androgen Deprivation in Combination With High-Dose Conformal Radiation Therapy in Intermediate- and High-Risk Localized Prostate Cancer
    Zapatero, A.
    Guerrero, A.
    Maldonado, J.
    Alvarez, A.
    Gonzalez San Segundo, C.
    Cabeza Rodriguez, M.
    Macias, V.
    Pedro-Olive, A.
    Casas, F.
    Boladeras, A.
    Martin de Vidales, C.
    Vazquez de la Torre, M.
    Calvo, F. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S1 - S1
  • [9] A Dose-Escalation Study for High-Dose-Rate Brachytherapy Boost in Intermediate- and High-Risk Prostate Cancer Patients
    Chiorda, B. Noris
    Blanchard, P.
    Calmels, L.
    Patard, J. J.
    Baumert, H.
    Moussier, A.
    Fizazi, K.
    Champoudry, J.
    Bossi, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E238 - E239
  • [10] High-dose rate brachytherapy for high-risk prostate cancer
    Schenck, M.
    Krause, K.
    Schwandtner, R.
    Haase, I.
    Fluehs, D.
    Friedrich, J.
    Jaeger, T.
    Boergermann, C.
    Ruebben, H.
    Stuschke, M.
    UROLOGE, 2006, 45 (06): : 715 - +